COMPARATIVE ANALYSIS OF ANTI-MULLERIAN HORMONE (AMH) AND FERTILITY IN WOMEN WITH AND WITHOUT POLYCYSTIC OVARY SYNDROME (PCOS)
TL;DR
The findings of this study reinforce the importance of incorporating AMH into the clinical evaluation of women of reproductive age and highlight the need to combine this parameter with clinical and imaging data for a more accurate diagnosis.
Abstract
Anti-Müllerian hormone (AMH) is one of the most important markers for assessing ovarian reserve and reproductive potential in women. The AMH level reflects the number of antral follicles and is widely used in clinical practice for the assessment of fertility and the diagnosis of disorders such as polycystic ovary syndrome (PCOS). The aim of this study is to analyze the distribution of AMH values and their relationship with age in a group of women. This study includes a retrospective analysis of 64 female women, for whom data on date of birth and serum levels of AMH, expressed in ng/mL, were collected. The results of this study demonstrate a significant relationship between AMH levels and ovarian function. Elevated AMH levels are strongly associated with the possible presence of PCOS, whereas low AMH levels reflect diminished ovarian reserve, often related to advancing age. The findings of this study reinforce the importance of incorporating AMH into the clinical evaluation of women of reproductive age and highlight the need to combine this parameter with clinical and imaging data for a more accurate diagnosis.